Equate Beauty

Description

The product is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet, which is debossed with "A" on one side and "B" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes the following inactive ingredients: microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hydroxypropyl methylcellulose, titanium dioxide, polyethylene glycol, iron oxide red, and iron oxide yellow.

Uses and Indications

This drug is indicated for the treatment of pimples (acne).

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

New users should initially apply the product to a small area of skin to test for sensitivity. If no discomfort is experienced, the product may be applied to the affected area. Following application, the product should be rinsed off.

The recommended starting regimen involves one application, with the possibility of gradually increasing the frequency to 2-3 times daily, as needed or as directed by a physician.

Contraindications

There are no specific contraindications identified for this product. However, healthcare professionals should advise patients to discontinue use and consult a physician if irritation, dryness, or redness develops and persists. Additionally, it is recommended that patients seek medical advice prior to use if they are pregnant or breastfeeding. Care should be taken to avoid contact with the eyes; in the event of contact, the eyes should be rinsed thoroughly with water for 15 minutes.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from sources of heat or fire to prevent any risk of ignition.

Healthcare professionals are advised to exercise caution when recommending this product in conjunction with other topical acne medications. Patients should be instructed to consult their doctor or pharmacist prior to use if they are currently using or have recently used other topical acne treatments. Concurrent use may exacerbate skin dryness or irritation; in such cases, it is recommended that only one medication be utilized unless otherwise directed by a healthcare provider.

In the event of accidental ingestion, immediate medical assistance should be sought, or the Poison Control Center should be contacted without delay.

Patients should be advised to discontinue use and consult a physician if they experience persistent irritation, dryness, or redness. Additionally, it is important to inquire about the use of this product in pregnant or breastfeeding individuals, as further consultation with a healthcare provider is warranted in these cases.

Side Effects

Patients should discontinue use and consult a healthcare professional if they experience irritation, dryness, or redness that develops and persists. These reactions warrant medical evaluation to determine the appropriate course of action.

Drug Interactions

Concurrent use of this product with other topical acne medications should be approached with caution. The combination may lead to increased dryness or irritation of the skin. It is advisable for patients to consult with a healthcare professional, such as a doctor or pharmacist, prior to using this product alongside other topical acne treatments.

In cases where increased dryness or irritation is experienced, it is recommended that only one topical acne medication be utilized at a time, unless otherwise directed by a healthcare provider. Monitoring for skin reactions is essential to ensure patient safety and comfort.

Packaging & NDC

Below are the non-prescription pack sizes of Equate Beauty (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

Elderly patients may not have specific information regarding the use of EQUATE BEAUTY - salicylic acid soap, as the drug insert does not provide details on dosage adjustments, safety concerns, or special precautions for this population. Healthcare providers should exercise caution when recommending this product to geriatric patients, considering the absence of data that may inform its safety and efficacy in this age group. Monitoring for any adverse effects or unusual reactions is advisable when elderly patients use this product.

Pregnancy

Pregnant patients and those who are breastfeeding should consult their healthcare provider before using this medication. It is important to assess the potential risks and benefits associated with the use of this drug during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and its effects on fetal outcomes are not fully understood. Therefore, healthcare professionals are advised to evaluate the necessity of treatment in this population carefully.

Lactation

Lactating mothers are advised to consult their healthcare provider prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, careful consideration and professional guidance are recommended to ensure the safety and well-being of both the mother and the nursing infant.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider individual patient factors when prescribing to patients with reduced kidney function, as the absence of specific guidance necessitates careful clinical judgment.

Hepatic Impairment

There is no available information regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the individual patient's liver status when prescribing this medication.

Overdosage

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center without delay. Prompt action is crucial to ensure the safety and well-being of the patient.

Healthcare professionals should be aware that symptoms of overdosage may vary depending on the substance involved. Therefore, a thorough assessment of the patient's condition is essential.

Management of overdosage should be guided by the specific clinical scenario and may include supportive care and symptomatic treatment. Continuous monitoring of the patient's vital signs and clinical status is recommended to address any complications that may arise.

In all cases of suspected overdosage, it is vital to gather as much information as possible regarding the substance, the amount ingested, and the time of ingestion to facilitate appropriate medical intervention.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology. As such, the assessment of potential risks related to these aspects remains unaddressed.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, they should seek medical help or contact a Poison Control Center immediately.

Patients should be instructed to discontinue use and consult a doctor if they experience irritation, dryness, or redness that persists. Additionally, it is important to recommend that patients consult their healthcare provider before using this product if they are pregnant or breastfeeding.

While using this product, patients should be cautioned to avoid contact with their eyes. If contact occurs, they should rinse their eyes thoroughly with water for at least 15 minutes.

Patients should also be encouraged to speak with their doctor or pharmacist before using this product if they are currently using other topical acne medications, as concurrent use may increase the risk of skin dryness or irritation. If such reactions occur, only one medication should be used unless otherwise directed by a healthcare professional.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The product is administered topically. New users are advised to apply it to a small area to test for sensitivity before applying it to the affected area. If no discomfort occurs, the product can be rinsed off after application. Initial use should start with one application, which may be gradually increased to 2-3 times daily as needed or as directed by a physician.

Clinicians should counsel patients to consult with a doctor or pharmacist before using this product concurrently with other topical acne medications, as this may exacerbate skin dryness or irritation. Patients should discontinue use and seek medical advice if they experience persistent irritation, dryness, or redness. Additionally, it is important to consult a healthcare professional if pregnant or breastfeeding. The product should be kept out of reach of children, and in the event of accidental ingestion, medical assistance or contact with a Poison Control Center is recommended.

Drug Information (PDF)

This file contains official product information for Equate Beauty, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)